Extended Ambulatory Monitoring Improves Risk Stratification in Hypertrophic Cardiomyopathy

Status unconfirmed

Conditions studied: Hypertrophic Cardiomyopathy

In brief

Eligible subjects will wear 4 consecutive external monitoring devices for a total of 28 days of monitoring.

Key facts

Study ID

NCT03182153

Run by

Atlantic Health System

People needed

83

Starts

2016-11-01

Expected to finish

2018-12-31

Last updated by the study team

2018-06-27

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Clinical diagnosis of HCM Scheduled for routine ambulatory monitoring for risk stratification Followed at the Chanin T. Mast HCM Center at Morristown Medical Center

You may not qualify if…

• Prior implantation of an ICD History of persistent/permanent atrial fibrillation (AF)

Where it is running

• Morristown Medical Center — Morristown, New Jersey, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.